# Lymphoma, Large B-Cell studies recruiting: 41 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 41 trials that are observational for Lymphoma, Large B-Cell, Diffuse that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational Lymphoma, Large B-Cell, Diffuse studies: 41 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/lymphoma-large-b-cell-diffuse

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 41
- Recruiting or not yet: 41
- Read on: November 19, 2026

## Trials

The 25 newest of 41, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 16, 2026 | NCT07878351 | Prospective ctDNA Testing in Large B-Cell Lymphoma | Peking University People's Hospital | Observational | Recruiting | Diffuse Large B Cell Lymphoma (DLBCL), High Grade B Cell Lymphoma | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07878351) |
| October 7, 2026 | NCT07862764 | A Study to Assess Change in Disease State and Adverse Events in Korean Adult Patients With Relapsed or Refractory Diffuse Large B-Cell... | AbbVie | Observational | Not yet recruiting | Diffuse Large B-Cell Lymphoma | 175 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07862764) |
| September 4, 2026 | NCT07804173 | Tumour Immune and Ki-67 Scoring Methods as Prognostic Biomarkers in Diffuse Large B-cell Lymphoma and Aggressive B-cell Lymphomas | Sohag University | Observational | Not yet recruiting | Diffuse Large B-cell Lymphoma and Aggressive B-cell Lymphomas | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07804173) |
| August 6, 2026 | NCT07750886 | Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL) | Natera, Inc. | Observational | Recruiting | Non-Hodgkin Lymphoma, T-Cell Lymphoma, Diffuse Large B-Cell Lymphoma, High-Grade B-Cell Lymphoma, Primary Mediastinal... | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07750886) |
| June 25, 2026 | NCT07669194 | Glofitamab Combined With Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma | Second Affiliated Hospital, Zhejiang University, School of Medicine | Observational | Not yet recruiting | Diffuse Large B-Cell Lymphoma (DLBCL) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07669194) |
| June 17, 2026 | NCT07652476 | Neurocognitive Assessment in Long-Term Survivors of Lymphoma | Fondazione Italiana Linfomi - ETS | Observational | Not yet recruiting | Classic Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), Primary Mediastinal B Cell Lymphoma | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07652476) |
| March 11, 2026 | NCT07463781 | Neurocognitive Assessment in Adults Undergoing CD19 Targeted CAR-T Cell Therapy | Fondazione Italiana Linfomi - ETS | Observational | Not yet recruiting | Diffuse Large B Cell Lymphoma (DLBCL), High Grade B Cell Lymphoma, Primary Mediastinal B-cell Lymphoma (PMBCL) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07463781) |
| December 30, 2025 | NCT07310186 | Treatment and Outcomes of DLBCL After Progression on Polatuzumab Vedotin-based Combination Therapy | Peking Union Medical College Hospital | Observational | Not yet recruiting | Diffuse Large B Cell Lymphoma (DLBCL) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07310186) |
| October 1, 2025 | NCT07200375 | An Observational Study of Glofitamab in Chinese Adult Participants With 2L Diffuse Large B-Cell Lymphoma | Hoffmann-La Roche | Observational | Recruiting | Diffuse Large B-Cell Lymphoma | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07200375) |
| September 30, 2025 | NCT07198230 | Drug-Eluting Bead-Based Transarterial Chemoembolization (DEB-TACE) as a Local Salvage Therapy for Large Lesions in Relapsed and Refractory... | Sponsor not shown (see the record) | Observational | Recruiting | Diffuse Large B-Cell Lymphoma, Relapsed and Refractory, Transarterial Chemoembolization | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07198230) |
| September 23, 2025 | NCT07188077 | Metabolic and Immunomic Differential Analysis of Primary Central Nervous System Diffuse Large B-Cell Lymphoma | Sponsor not shown (see the record) | Observational | Recruiting | Primary Central Nervous System Lymphoma (PCNSL), Diffuse Large B-Cell Lymphoma | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07188077) |
| July 17, 2025 | NCT07070648 | Study on Predicting Response to Standard First-Line Treatment in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Using ctDNA Combined With... | Fudan University | Observational | Recruiting | Diffuse Large B-Cell Lymphoma, DLBCL | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07070648) |
| February 17, 2025 | NCT06830759 | Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma | AbbVie | Observational | Recruiting | Diffuse Large B-cell Lymphoma, Follicular Lymphoma | 700 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06830759) |
| February 12, 2025 | NCT06822829 | Multicenter Retrospective Observational Study of Relapsed Diffuse Large B-Cell Lymphoma Presenting as Indolent Lymphoma | Azienda USL Reggio Emilia - IRCCS | Observational | Recruiting | Diffuse Large B Cell Lymphoma (DLBCL), Indolent B-Cell Lymphomas, Indolent B Cell Lymphoma | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06822829) |
| January 21, 2025 | NCT06785818 | Long-term Follow up Local Registry Study of Kymriah in South Korea | Novartis Pharmaceuticals | Observational | Recruiting | B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06785818) |
| January 20, 2025 | NCT06784167 | Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment | OHSU Knight Cancer Institute | Observational | Recruiting | Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Multiple... | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06784167) |
| January 1, 2025 | NCT06755775 | PET Imaging Targeting Granzyme B Predicts Immunotherapy Efficacy in Diffuse Large B-cell Lymphoma | Ruijin Hospital | Observational | Recruiting | Diffuse Large B-Cell Lymphoma | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06755775) |
| December 16, 2024 | NCT06734624 | The Microbiome in Blood Cancer and HLH | University of Nottingham | Observational | Not yet recruiting | Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Haemophagocytic Lymphohistiocytosis | 750 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06734624) |
| October 24, 2024 | NCT06656234 | The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse... | Ruijin Hospital | Observational | Not yet recruiting | Diffuse Large B Cell Lymphoma (DLBCL) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06656234) |
| September 19, 2024 | NCT06588205 | Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and... | Fondazione Italiana Linfomi - ETS | Observational | Recruiting | Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6... | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06588205) |
| August 27, 2024 | NCT06573099 | A Real-World Study on Extranodal Lymphoma | Ruijin Hospital | Observational | Not yet recruiting | Lymphoma, Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Extranodal Lymphoma, Diffuse Large B Cell Lymphoma | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06573099) |
| June 3, 2024 | NCT06439173 | Study of the Hematopoietic Niche and the Role of Inflammation in the Pathophysiology of Cytopenias After CAR-T Cell Therapy: Potential of... | Instituto de Investigación Biomédica de Salamanca | Observational | Recruiting | Diffuse Large B Cell Lymphoma | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06439173) |
| March 21, 2024 | NCT06323447 | Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia | Leuko Labs, Inc. | Observational | Recruiting | Diffuse Large B Cell Lymphoma, Multiple Myeloma | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06323447) |
| January 25, 2024 | NCT06224309 | Preliminary Assessment of \[18F\]BL40 in PET/CT Scans | British Columbia Cancer Agency | Observational | Recruiting | Diffuse Large B-cell Lymphoma, Multiple Myeloma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06224309) |
| November 14, 2023 | NCT06131801 | Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution | Children's Hospital Medical Center, Cincinnati | Observational | Recruiting | Hematologic Malignancy, Leukemia, Lymphoma, Acute Lymphocytic Leukemia, ALL, Acute Myelogenous Leukemia, AML, Chronic... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06131801) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Ruijin Hospital | 4 |
| Fondazione Italiana Linfomi - ETS | 3 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 2 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 2 |
| Peking University People's Hospital | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| [iOMEDICO AG](https://specstream.ai/data/clinical-trials/company/iomedico-ag) | 1 |
| University of Nottingham | 1 |
| OHSU Knight Cancer Institute | 1 |
| Oncology Institute of Southern Switzerland | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Azienda USL Reggio Emilia - IRCCS | 1 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 1 |
| Instituto de Investigación Biomédica de Salamanca | 1 |
| [Miltenyi Biomedicine GmbH](https://specstream.ai/data/clinical-trials/company/miltenyi-biomedicine-gmbh) | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| Peking Union Medical College Hospital | 1 |
| Emory University | 1 |
| Fudan University | 1 |
| [Natera, Inc.](https://specstream.ai/data/clinical-trials/company/natera-inc) | 1 |
| Pell Bio-Med Technology Co., Ltd. | 1 |
| Sohag University | 1 |
| JaxBio Ltd | 1 |
| British Columbia Cancer Agency | 1 |
| Medical College of Wisconsin | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 10 |
| China | 9 |
| Italy | 8 |
| Spain | 3 |
| United Kingdom | 2 |
| Greece | 2 |
| Israel | 2 |
| Canada | 2 |
| Germany | 1 |
| Brazil | 1 |
| Switzerland | 1 |
| South Korea | 1 |
| Hong Kong | 1 |
| Taiwan | 1 |
| Egypt | 1 |
| Czechia | 1 |
| Lithuania | 1 |
| Argentina | 1 |
| Australia | 1 |
| Austria | 1 |
| Belgium | 1 |
| Bulgaria | 1 |
| Mexico | 1 |
| Portugal | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Rail services in the United States](https://specstream.ai/data/businesses/rail-services/united-states)
- [Optometrists in the United States](https://specstream.ai/data/businesses/optometrists/united-states)
- [Kitchen remodelers in the United States](https://specstream.ai/data/businesses/kitchen-remodelers/united-states)
- [Geological services in the United States](https://specstream.ai/data/businesses/geological-services/united-states)
- [Dumpster rental companies in the United States](https://specstream.ai/data/businesses/dumpster-rental-companies/united-states)
- [Caribbean restaurants in the United States](https://specstream.ai/data/businesses/caribbean-restaurants/united-states)
